Cargando…

Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome

BACKGROUND: It is unknown whether atrial fibrillation (AF) burden varies by pacing site in patients with reactive atrial antitachycardia pacing (rATP). We aimed to compare AF burden in patients with high atrial septal pacing (HASp) via delivery catheter and right atrial appendage pacing (RAAp) in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumiyoshi, Hironobu, Tasaka, Hiroshi, Yoshida, Kenta, Yoshino, Mitsuru, Kadota, Kazushige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407182/
https://www.ncbi.nlm.nih.gov/pubmed/37560282
http://dx.doi.org/10.1002/joa3.12888
_version_ 1785085900076613632
author Sumiyoshi, Hironobu
Tasaka, Hiroshi
Yoshida, Kenta
Yoshino, Mitsuru
Kadota, Kazushige
author_facet Sumiyoshi, Hironobu
Tasaka, Hiroshi
Yoshida, Kenta
Yoshino, Mitsuru
Kadota, Kazushige
author_sort Sumiyoshi, Hironobu
collection PubMed
description BACKGROUND: It is unknown whether atrial fibrillation (AF) burden varies by pacing site in patients with reactive atrial antitachycardia pacing (rATP). We aimed to compare AF burden in patients with high atrial septal pacing (HASp) via delivery catheter and right atrial appendage pacing (RAAp) in patients with sick sinus syndrome (SSS). METHODS: We retrospectively identified 109 patients with a history of paroxysmal AF and SSS who had received dual‐chamber pacemaker implantation between January 2017 and December 2019, of whom 39 and 70 patients had HASp and RAAp, respectively. rATP was initiated after a 1‐month post‐implantation run‐in period. RESULTS: Patients with HASp had a significantly shorter P‐wave duration during atrial pacing than those with RAAp (99.3 ± 10.4 vs. 116.0 ± 14.3 ms, p < .001). During the 3‐year follow‐up period, the incidence of an AF lasting longer than 1 or 7 days was significantly lower (hazard ratio [HR], 0.45; p = .016; HR, 0.24; p = .004) than in those with RAAp. The median time of AF/AT per day in the follow‐up periods was significantly shorter in the HASp group than in the RAAp group (10 vs. 18 min/day, p = .018). Atrial lead division did not occur in the HASp group during the follow‐up period. CONCLUSIONS: HASp via delivery catheter is as safe as RAAp, and HASp combined with rATP is effective for reducing AF burden in patients with SSS and paroxysmal AF.
format Online
Article
Text
id pubmed-10407182
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104071822023-08-09 Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome Sumiyoshi, Hironobu Tasaka, Hiroshi Yoshida, Kenta Yoshino, Mitsuru Kadota, Kazushige J Arrhythm Original Articles BACKGROUND: It is unknown whether atrial fibrillation (AF) burden varies by pacing site in patients with reactive atrial antitachycardia pacing (rATP). We aimed to compare AF burden in patients with high atrial septal pacing (HASp) via delivery catheter and right atrial appendage pacing (RAAp) in patients with sick sinus syndrome (SSS). METHODS: We retrospectively identified 109 patients with a history of paroxysmal AF and SSS who had received dual‐chamber pacemaker implantation between January 2017 and December 2019, of whom 39 and 70 patients had HASp and RAAp, respectively. rATP was initiated after a 1‐month post‐implantation run‐in period. RESULTS: Patients with HASp had a significantly shorter P‐wave duration during atrial pacing than those with RAAp (99.3 ± 10.4 vs. 116.0 ± 14.3 ms, p < .001). During the 3‐year follow‐up period, the incidence of an AF lasting longer than 1 or 7 days was significantly lower (hazard ratio [HR], 0.45; p = .016; HR, 0.24; p = .004) than in those with RAAp. The median time of AF/AT per day in the follow‐up periods was significantly shorter in the HASp group than in the RAAp group (10 vs. 18 min/day, p = .018). Atrial lead division did not occur in the HASp group during the follow‐up period. CONCLUSIONS: HASp via delivery catheter is as safe as RAAp, and HASp combined with rATP is effective for reducing AF burden in patients with SSS and paroxysmal AF. John Wiley and Sons Inc. 2023-06-26 /pmc/articles/PMC10407182/ /pubmed/37560282 http://dx.doi.org/10.1002/joa3.12888 Text en © 2023 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Sumiyoshi, Hironobu
Tasaka, Hiroshi
Yoshida, Kenta
Yoshino, Mitsuru
Kadota, Kazushige
Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome
title Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome
title_full Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome
title_fullStr Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome
title_full_unstemmed Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome
title_short Combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome
title_sort combined effects of high atrial septal pacing and reactive atrial antitachycardia pacing for reducing atrial fibrillation in sick sinus syndrome
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407182/
https://www.ncbi.nlm.nih.gov/pubmed/37560282
http://dx.doi.org/10.1002/joa3.12888
work_keys_str_mv AT sumiyoshihironobu combinedeffectsofhighatrialseptalpacingandreactiveatrialantitachycardiapacingforreducingatrialfibrillationinsicksinussyndrome
AT tasakahiroshi combinedeffectsofhighatrialseptalpacingandreactiveatrialantitachycardiapacingforreducingatrialfibrillationinsicksinussyndrome
AT yoshidakenta combinedeffectsofhighatrialseptalpacingandreactiveatrialantitachycardiapacingforreducingatrialfibrillationinsicksinussyndrome
AT yoshinomitsuru combinedeffectsofhighatrialseptalpacingandreactiveatrialantitachycardiapacingforreducingatrialfibrillationinsicksinussyndrome
AT kadotakazushige combinedeffectsofhighatrialseptalpacingandreactiveatrialantitachycardiapacingforreducingatrialfibrillationinsicksinussyndrome